NL8002388A - Roentgencontrastmiddel. - Google Patents
Roentgencontrastmiddel. Download PDFInfo
- Publication number
- NL8002388A NL8002388A NL8002388A NL8002388A NL8002388A NL 8002388 A NL8002388 A NL 8002388A NL 8002388 A NL8002388 A NL 8002388A NL 8002388 A NL8002388 A NL 8002388A NL 8002388 A NL8002388 A NL 8002388A
- Authority
- NL
- Netherlands
- Prior art keywords
- contrast agent
- ionic
- aqueous solution
- viscosity
- ray contrast
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
- A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
- A61K49/0452—Solutions, e.g. for injection
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4057079A | 1979-05-21 | 1979-05-21 | |
US4057079 | 1979-05-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
NL8002388A true NL8002388A (nl) | 1980-11-25 |
Family
ID=21911706
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NL8002388A NL8002388A (nl) | 1979-05-21 | 1980-04-24 | Roentgencontrastmiddel. |
Country Status (7)
Country | Link |
---|---|
JP (1) | JPS55154920A (fr) |
AU (1) | AU5856480A (fr) |
BE (1) | BE883383A (fr) |
DE (1) | DE3018515A1 (fr) |
FR (1) | FR2457104A1 (fr) |
GB (1) | GB2050167A (fr) |
NL (1) | NL8002388A (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1256248B (it) * | 1992-12-24 | 1995-11-29 | Bracco Spa | Formulazioni iniettabili acquose per radiodiagnostica comprendenti miscele di composti aromatici iodurati utili come agenti opacizzanti ai raggi x |
DE19627309C2 (de) * | 1996-06-27 | 1999-07-29 | Schering Ag | Wäßrige injizierbare Formulierungen verwendbar als Kontrastmittel |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2613172A (en) * | 1949-08-10 | 1952-10-07 | American Cystoscope Makers Inc | X-ray contrast compositions |
US2921884A (en) * | 1957-09-30 | 1960-01-19 | Sterling Drug Inc | Pharmaceutical compositions |
AT332534B (de) * | 1972-04-12 | 1976-10-11 | Beecham Group Ltd | Rontgenkontrastmittel |
CH608189A5 (fr) * | 1974-12-13 | 1978-12-29 | Savac Ag |
-
1980
- 1980-04-24 NL NL8002388A patent/NL8002388A/nl not_active Application Discontinuation
- 1980-05-14 DE DE19803018515 patent/DE3018515A1/de not_active Withdrawn
- 1980-05-16 GB GB8016355A patent/GB2050167A/en not_active Withdrawn
- 1980-05-20 JP JP6602380A patent/JPS55154920A/ja active Pending
- 1980-05-20 AU AU58564/80A patent/AU5856480A/en not_active Abandoned
- 1980-05-20 FR FR8011255A patent/FR2457104A1/fr active Pending
- 1980-05-20 BE BE0/200680A patent/BE883383A/fr unknown
Also Published As
Publication number | Publication date |
---|---|
BE883383A (fr) | 1980-11-20 |
FR2457104A1 (fr) | 1980-12-19 |
AU5856480A (en) | 1980-11-27 |
GB2050167A (en) | 1981-01-07 |
JPS55154920A (en) | 1980-12-02 |
DE3018515A1 (de) | 1980-12-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Moore et al. | Moderation. | |
JP3585233B2 (ja) | レントゲン撮影造影剤としてヨウ化芳香族化合物を使用する放射線診断用注射剤水溶液 | |
Mitra et al. | Are all colloids same? How to select the right colloid? | |
EP2178568B1 (fr) | Produits de contraste | |
FI82605B (fi) | Foerfarande foer framstaellning av encellskikt och vaevnader skyddande kondroitinsulfat-natriumhyaluronat -komposition. | |
Hardeman et al. | The effect of low-osmolar ionic and nonionic contrast media on human blood viscosity, erythrocyte morphology, and aggregation behavior | |
Cheng et al. | Influence of semiperfluorinated chains on the liquid crystalline properties of amphiphilic polyols: novel materials with thermotropic lamellar, columnar, bicontinuous cubic, and micellar cubic mesophases | |
EP1732953A2 (fr) | Hydroxyethylamidon | |
Kulicke et al. | Improvements in polysaccharides for use as blood plasma expanders | |
RO111543B1 (ro) | Mediu de contrast | |
NL8002388A (nl) | Roentgencontrastmiddel. | |
NO145370B (no) | Fremgangsmaate for fremstilling av et varme- og lagringsstabilt bloderstatningsmiddel bestaaende av en blanding av oksygenoverfoerende perfluorkarbonforbindelser | |
Berg et al. | Investigation of the tolerance of the rabbit's kidney to newer contrast media in renal angiography | |
Strickland et al. | Contrast media-induced effects on blood rheology and their importance in angiography | |
JPS6084225A (ja) | 点眼剤 | |
Bååth et al. | Reduction of the risk of ventricular fibrillation in the isolated rabbit heart by small additions of electrolytes to non-ionic monomeric contrast media | |
Szabó | The syndrome of fat embolism and its origin. | |
Araki et al. | Newly developed transarterial chemoembolization material: CDDP—lipiodol suspension | |
Finestone et al. | Effects of bile and bile salt infusions on renal function in dogs | |
JPS6049164B2 (ja) | 血漿増量剤 | |
Havdrup et al. | Papain-induced mitosis of chondrocytes in adult joint cartilage: an experimental study in full-grown rabbits | |
Barbe et al. | Effects of Contrast Media on Circulating Blood Volume: A Comparative Investigation of Various Sites of Injection | |
Johansen et al. | Arthrography of the knee joint with Amipaque | |
JPH09104627A (ja) | アパファントを主薬とする水性点眼剤 | |
CENTENO et al. | Brain changes on computed tomography following metrizamide myelography: significance and therapeutic implications |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
BV | The patent application has lapsed |